TABLE 4.
Prevalence of resistance genes in clinical isolates
Resistance gene(s) | Prevalences for isolates by type: |
|||||||
---|---|---|---|---|---|---|---|---|
Total |
Clinical, Germany |
Clinical, Trinidad and Tobago |
Veterinary, Germany |
|||||
No. resistant | % | No. resistant | % | No. resistant | % | No. resistant | % | |
erm(A) | 26 | 5.8 | 26 | 6.8 | 0 | 0.0 | 0 | 0.0 |
erm(B) | 47 | 10.5 | 44 | 11.5 | 0 | 0.0 | 3 | 14.3 |
erm(C) | 8 | 1.8 | 8 | 2.1 | 0 | 0.0 | 0 | 0.0 |
tet(M) | 345 | 77.0 | 306 | 79.7 | 24 | 70.6 | 10 | 47.6 |
emrB/qacA | 448 | 100.0 | 384 | 100.0 | 34 | 100.0 | 21 | 100.0 |
cadC | 95 | 21.2 | 86 | 22.4 | 6 | 17.6 | 0 | 0.0 |
cadD | 400 | 89.3 | 352 | 91.7 | 32 | 94.1 | 10 | 47.6 |
merR + merA | 213 | 47.5 | 176 | 45.8 | 30 | 88.2 | 1 | 4.8 |